Thrombogenicity of dialyzer membranes as assessed by residual blood volume and surface morphology at different heparin dosages.
Debrand-Passard
A
A
Medizinische Klinik und Poliklinik, Freien Universität Berlin, BRD.
Lajous-Petter
A
A
Schmidt
R
R
Herbst
R
R
von Baeyer
H
H
Krause
A A
AA
Schiffl
H
H
D000368:Aged; D000369:Aged, 80 and over; D001792:Blood Platelets / Q000378:metabolism; D001810:Blood Volume / Q000187:drug effects*; D002448:Cell Adhesion / Q000187:drug effects; D002482:Cellulose; D004305:Dose-Response Relationship, Drug; D005260:Female; D005337:Fibrin / Q000378:metabolism; D006331:Heart Diseases / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007962:Leukocytes / Q000378:metabolism; D008297:Male; D008567:Membranes, Artificial; D008768:Methylmethacrylates; D006435:Renal Dialysis / Q000009:adverse effects* / Q000295:instrumentation; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control
D008567:Membranes, Artificial; D008768:Methylmethacrylates; D005337:Fibrin; D002482:Cellulose; D006493:Heparin